Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 9
2004 11
2005 9
2006 6
2007 5
2008 9
2009 11
2010 13
2011 15
2012 13
2013 12
2014 16
2015 21
2016 14
2017 17
2018 30
2019 27
2020 20
2021 28
2022 25
2023 23
2024 22
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Roadmap on semiconductor-cell biointerfaces.
Tian B, Xu S, Rogers JA, Cestellos-Blanco S, Yang P, Carvalho-de-Souza JL, Bezanilla F, Liu J, Bao Z, Hjort M, Cao Y, Melosh N, Lanzani G, Benfenati F, Galli G, Gygi F, Kautz R, Gorodetsky AA, Kim SS, Lu TK, Anikeeva P, Cifra M, Krivosudský O, Havelka D, Jiang Y. Tian B, et al. Among authors: galli g. Phys Biol. 2018 Mar 9;15(3):031002. doi: 10.1088/1478-3975/aa9f34. Phys Biol. 2018. PMID: 29205173 Free PMC article. Review.
Spermatocytic Tumor: A Review.
Secondino S, Viglio A, Neri G, Galli G, Faverio C, Mascaro F, Naspro R, Rosti G, Pedrazzoli P. Secondino S, et al. Among authors: galli g. Int J Mol Sci. 2023 May 31;24(11):9529. doi: 10.3390/ijms24119529. Int J Mol Sci. 2023. PMID: 37298487 Free PMC article. Review.
Circulating biomarkers in malignant pleural mesothelioma.
Viscardi G, Di Natale D, Fasano M, Brambilla M, Lobefaro R, De Toma A, Galli G. Viscardi G, et al. Among authors: galli g. Explor Target Antitumor Ther. 2020;1(6):434-451. doi: 10.37349/etat.2020.00028. Epub 2020 Dec 28. Explor Target Antitumor Ther. 2020. PMID: 36046389 Free PMC article. Review.
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease.
Bertuccio FR, Agustoni F, Galli G, Bortolotto C, Saddi J, Baietto G, Baio N, Montini S, Putignano P, D'Ambrosio G, Corsico AG, Pedrazzoli P, Stella GM. Bertuccio FR, et al. Among authors: galli g. Cancers (Basel). 2023 Dec 6;15(24):5731. doi: 10.3390/cancers15245731. Cancers (Basel). 2023. PMID: 38136277 Free PMC article. Review.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Prelaj A, Ganzinelli M, Provenzano L, Mazzeo L, Viscardi G, Metro G, Galli G, Agustoni F, Corte CMD, Spagnoletti A, Giani C, Ferrara R, Proto C, Brambilla M, Dumitrascu AD, Inno A, Signorelli D, Pizzutilo EG, Brighenti M, Biello F, Bennati C, Toschi L, Russano M, Cortellini A, Catania C, Bertolini F, Berardi R, Cantini L, Pecci F, Macerelli M, Emili R, Bareggi C, Verderame F, Lugini A, Pisconti S, Buzzacchino F, Aieta M, Tartarone A, Spinelli G, Vita E, Grisanti S, Trovò F, Auletta P, Lorenzini D, Agnelli L, Sangaletti S, Mazzoni F, Calareso G, Ruggirello M, Greco GF, Vigorito R, Occhipinti M, Manglaviti S, Beninato T, Leporati R, Ambrosini P, Serino R, Silvestri C, Zito E, Pedrocchi ACL, Miskovic V, de Braud F, Pruneri G, Lo Russo G, Genova C, Vingiani A. Prelaj A, et al. Among authors: galli g. Clin Lung Cancer. 2024 Mar;25(2):190-195. doi: 10.1016/j.cllc.2023.12.012. Epub 2023 Dec 22. Clin Lung Cancer. 2024. PMID: 38262770 Free article.
Clinical Trials of Cellular Therapies in Solid Tumors.
Secondino S, Canino C, Alaimo D, Muzzana M, Galli G, Borgetto S, Basso S, Bagnarino J, Pulvirenti C, Comoli P, Pedrazzoli P. Secondino S, et al. Among authors: galli g. Cancers (Basel). 2023 Jul 19;15(14):3667. doi: 10.3390/cancers15143667. Cancers (Basel). 2023. PMID: 37509328 Free PMC article. Review.
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Manglaviti S, Bini M, Apollonio G, Zecca E, Galli G, Sangaletti S, Labianca A, Sottotetti E, Brambilla M, Occhipinti M, Proto C, Prelaj A, Signorelli D, De Toma A, Viscardi G, Beninato T, Mazzeo L, Bottiglieri A, Leporati R, Fotia G, Ganzinelli M, Portararo P, Garassino MC, de Braud FGM, Lo Russo G, Torri V, Ferrara R. Manglaviti S, et al. Among authors: galli g. Lung Cancer. 2023 Dec;186:107417. doi: 10.1016/j.lungcan.2023.107417. Epub 2023 Oct 29. Lung Cancer. 2023. PMID: 37918061
CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency.
Bortolotto C, Pinto A, Brero F, Messana G, Cabini RF, Postuma I, Robustelli Test A, Stella GM, Galli G, Mariani M, Figini S, Lascialfari A, Filippi AR, Bottinelli OM, Preda L. Bortolotto C, et al. Among authors: galli g. Eur Radiol Exp. 2024 Jun 17;8(1):71. doi: 10.1186/s41747-024-00468-8. Eur Radiol Exp. 2024. PMID: 38880866 Free PMC article.
336 results